In this webinar, we will establish the medical backdrop for COVID-19 virus sequencing in drug development, connect insights from population surveillance to potential solutions for drug developers, describe the biological relevance of sequencing in drug development, and outline approaches to COVID-19 virus sequencing, including the application of both targeted and whole genome sequencing to drug development. Register now!
In November, clinical trial platform developer Medable raised $91 million in private funding, amid the COVID-19 pandemic that touched off huge demand among pharmaceutical companies looking to initiate “siteless” or virtual clinical trials. This webinar will explore the role of CROs in siteless trials and the opportunities and challenges for CROs to expand their capabilities in this burgeoning area. Register now.
In today’s complex market, emerging and mid-size pharmaceutical manufacturers require the expertise and supporting technologies, across multiple disciplines, to effectively maximize product revenue and optimize market access functions. Join us on July 22, as industry expert, Tracy Mumpower, shares strategies for integrating a Business Service operations model with your Commercial and Market Access teams, to continue to drive operational excellence and insights through the power of People, Process, and Technology. Register Now.
Real-world data are currently supporting decision making across the spectrum of oncology care. Join us as we discuss the current paradigm of oncology product development life cycle and the use of real-world oncology data to drive innovation, efficiencies, and improvements in patient outcomes. Register now.
In this webinar hear from “both sides of the house” – first from an innovative information technology leader and then a senior scientist who uses the solutions provided by IT. Learn how MOMA Therapeutics’ innovative lead discovery solution can be applied to the needs of your biotechnology discovery workflows. Save Your Spot.
The benefits of integrating IRB and IBC review processes were brought to light during the COVID pandemic. Working with an integrated IRB and IBC can streamline study startup for genetic engineering trials. In this whitepaper learn about: an overview of the IRB and IBC, understanding the IBC process, advancing COVID-19 vaccine development through integrated reviews, and the future of gene therapy. Download Now!
In this new white paper, our experts discuss various implementation science study designs, the role of continuous quality improvement, and share examples of studies that utilized implementation science to optimize product uptake. Read more.
Biopharmaceutical drug pricing and market access contracting have become more complicated and interrelated than ever. Join us to discuss how a more integrated, intuitive approach to pricing and contracting can create organizational agility. Discover how this inter-connected approach can have a radical impact on the profitability of life sciences organizations as well as align incentives across the health care ecosystems. Register now.
HitGen has established an industry-leading drug discovery platform for small molecules and nucleic acid drugs centered on the design, synthesis and screening of DNA encoded chemical libraries (DELs), fragment-based drug discovery (FBDD) and structure-based drug design (SBDD) technologies. HitGen founder Dr. Jin Li and Vernalis chief scientist Professor Rod Hubbard will join hands to illustrate advancing innovative drug discovery by DNA Encoded Library and FBDD/SBDD methods. Register Now.
Learn how a small, investigator-initiated project developed into a valuable COVID-19 chest CT dataset using Flywheel's research data management platform. You will also hear how Imbio is exploring the correlation between lung injury severity and patient prognosis, as well as developing AI to diagnose COVID-19. Digital transformation professionals, radiologists, data scientists, and clinical and translational imaging leads should attend to learn about integrating radiology research and AI solutions to enable collaboration and improve R&D efficiency. Register now.
The road to IND isn’t always easy. Balancing speed, risk, and future needs is a challenge. Join Paul Jorjorian, Vice President and General Manager, Thermo Fisher Scientific, and learn how you can take your molecule from discovery to FiH trials without undue risk or excessive timelines. Plus, find out how you can meet short-term goals while preparing for future commercialization success. Register Now.
This webinar focuses on manufacturing aspects that enable successful development and scale-up of the micronization process. Technical issues that must be investigated for successful development of effective API micronization will be explored. An overview of micronization and typical scale-up challenges will be presented along with a robust process development strategy to ensure critical-to-quality attributes are maintained. Register Now.
Life Sciences manufacturers that focus on streamlining the tendering and bidding process win more. Join our tender experts for a virtual session to learn strategies to optimize your bids, streamline processes, and improve collaboration and visibility across the tender lifecycle. You’ll also hear from Veronica Gil, Pricing & Tender Director, Baxter EMEA, on how her team leveraged technology to centralize processes and develop a winning tender strategy. Register Now.
Since its concept was conceived in 1992, DNA-encoded libraries (DELs) have evolved into a valuable technology for hit identification in drug discovery. The DEL technology enables the fast and economic synthesis, screening, and analysis of DNA-encoded collections of millions to trillions of compounds against biological targets through a confluence of molecular biology, combinatorial chemistry, high throughput sequencing and advanced informatics techniques. This whitepaper will provide the drug discovery community with a better understanding of DEL technology and stimulate innovation in the field by describing the DEL design, synthesis, screening and expanded applications. Download Now.
Nearly a quarter of adults worldwide are thought to have non-alcoholic fatty liver disease; between 11% and 40% of them will progress to non-alcoholic steatohepatitis (NASH). Join industry leaders for a webinar dedicated to overcoming key challenges presented in NASH drug development. We’ll explore key considerations for liver biopsy collection and interpretation, emerging non-invasive biomarkers, and the connection between clinical practice and drug development. Register now.
Join this webinar to hear experts share how dissolution tools and PBPK modeling can help evaluate whether a molecule is suitable for controlled release applications and predict the effects of release rate on in vitro performance. In addition, the experts will cover all aspects of oral controlled release technologies and discuss current strategies to select the optimal technology to meet the intended release profile. Register Now.
Healthcare is becoming more virtual and digital healthcare tools more common, which presents new challenges and opportunities for pharma sales. In response, brands are turning to innovative digital solutions to enhance and augment sales, including intelligent bots powered by conversational AI that can automate and augment HCP education and support. In this session, you’ll hear from leading agency experts working to transform HCP experiences with conversational AI voice and chatbots. Register Now.
COVID-19 has changed the diagnostic testing industry as a whole. A need for decentralized, easier, accurate, and rapid testing has never been more apparent. This whitepaper explores recent transformation and future of the point-of-care molecular diagnostics industry as a result of the pandemic, as well as assay development challenges/considerations for diagnostic test developers and new areas of application aside from infectious disease—oncology, non-invasive prenatal testing, inhered disease, and more. Download now.
Optimizing the manufacture and delivery of significant amounts of therapeutically potent cells, extend today’s frontiers in the field of cell therapy and regenerative medicine. Leaders in the pharma and biotech industry, health care sector and life science researchers will get insights about the latest advances in regenerative medicine, gene editing platforms, tackling the critical limitations in developing CRISPR therapeutics and more. Register Today.
Before COVID-19, the typical vaccine took more than five years to develop. Biopharma companies raced from virus discovery to phase 3 testing of their COVID-19 vaccines in under a year. Now the industry is asking an important question: Can we take what we learned from COVID-19 vaccine successes and use it to speed up the development of other vaccines? Register now.
For innovators working with oral small molecules, scale-up and technology transfer are critical drug product milestones to successfully reach product launch. Whether moving to a new equipment scale or transferring a drug product to a new facility ramping up from demonstration to commercial scale, manufacturers depend on a successful scale-up and transfer to maintain drug product efficacy, quality and ensure drug product safety. However, a range of technological (material and drug product manufacturing process) challenges can cause these efforts to be delayed or cancelled – at significant cost. Download this Executive Summary to Learn More.
Large or small, cyberattacks are making headlines and elevating executive attention toward cyber resiliency. During this session, we will explore security considerations for developing cyber resilience covering security fundamentals and readiness planning to protect your IT and OT environments. Register now.
The COVID-19 pandemic transformed the point-of-care (POC) diagnostic industry. Technologies that were on the periphery before the crisis such as isothermal amplification have become critical to the fight against the coronavirus, thus validating their potential through real-world use and accelerating adoption. The impact is extending well beyond COVID-19, with the crisis driving transitions to POC oncology, prenatal, and inherited disease testing. Faced with rapid change, test developers in this field are seeking out reliable suppliers of high-performing OEM components to keep up with the everchanging landscape. Learn more.
The Top 5-Ranked UF College of Pharmacy is pleased to announce a NEW online graduate program in pharmaceutics. Choose from certificate options in model-informed drug development (MIDD) this fall 2021 or clinical pharmacology and drug development in fall 2022. Learn more to advance your career.
The recently heightened awareness of racial discrimination coupled with COVID-19’s disproportionate toll on disadvantaged communities has spurred the need for change. Yet the lack of equity and representation of minority groups in clinical research has been an open concern for decades. Attendees will learn how to optimize patient diversity and inclusivity of clinical trials. Register Now.
As we head into ASCO weekend, cancer experts will highlight closely watched data sets to be unveiled at the meeting. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2021's biggest research trends, and the data they're most looking forward to seeing. Register now.
Learn how human pluripotent stem cells (hPSCs) are being manufactured at scale for clinical applications under current Good Manufacturing Practices (cGMPs) from Dr. Dhruv Sareen, the Executive Director of the Cedars-Sinai Biomanufacturing Center. Register Now.
When patients self-administer their medications, 60% do not take them as intended and over half of all patients are non-adherent. The resulting cost of non-adherence and non-optimized therapy is steep and everyone pays the price. The rules around healthcare engagement are now being rewritten, and technology has the potential to augment patient care, deliver value across the digital health ecosystem, and deliver better outcomes for all stakeholders in a more connected future. Register now.
Go where your patients are. GO BYOD to improve patient enrollment, retention, and compliance while recruiting a more diverse patient population. For better patient experience, higher quality data, and lower costs, consider BYOD for your next trial. Download Whitepaper Now.
Discover how Ashfield Healthcare uses the power of data and analytics to enable pre-call planning, inform sales rep actions and drive higher market share for its target pharmaceutical products. Learn now.
Janssen to highlight data from study of investigational bispecific antibody in patients with advanced non-small cell lung cancer with a certain genetic mutation. Click here to learn more.
Join us to review the first-in-human Phase 1 study of novel arenaviral therapeutics, HB-201 & HB-202, in advanced HPV16+ cancer patients (ASCO oral #2502). The program will highlight antigen-specific CD8+ T cell, anti-tumor activity and tolerability data, as well as implications for the future. Read more.
As science and technology companies continue to make advancements in vaccine and viral vector-based gene therapy development, there is an increasing need for analytical techniques that can help assess quality parameters, especially in real-time. In a step toward process improvements, Catalent recently partnered with LumaCyte’s Laser Force Cytology (LFC) instrument, Radiance®, to apply more rapid and accurate measurement of quality attributes—such as viral titer and infectivity—to cell testing. Download to learn more.
An evolution of biopharmaceutical manufacturing processes needs to happen if the cell and gene therapy field is to keep pace with the speed of science. Download this whitepaper to learn more about breaking down the challenges posed by constrained capacity, how custom processes hold the industry back, why standardization is now possible and how it’s accelerating R&D, and putting standard processes and products into practice. Learn more.
Learn how Philips and QIAGEN are using mRNA technology in OncoSignal tests to quantify functional activity of disease-relevant signal transduction pathways in any cell and tissue type. This webinar will explore applications for both preclinical disease modeling and clinical measurement of response to targeted therapies and immunotherapies. Register now.
FDA is opening up to data gathered outside the hermetically sealed clinical trial setting as regulators recognize the need for a more flexible framework for evaluating treatments. As a new approach that requires significant investment, RWE use requires the right talent and technology. Where to find those resources and how to deploy them are some of the questions companies face. We’ll address these questions and more with the help of current practitioners in the field. Register now.
Create a more diverse and inclusive clinical trial enrollment and engagement environment with strategic guidance from BBK Worldwide and IRB insight from Advarra. Download now.
Interested in digitizing your R&D organization, but not sure where to start? Looking to move from a wealth of spreadsheets and outdated software systems into one centralized data repository? This webinar shows what a modern software system should look like for R&D and how that compares to how most companies operate today. Register Today!
Autologous cell and gene therapy workflows involve isolating cells from an individual, engineering the cells, expanding and concentrating them, and infusing them back into the patient. Optimized automation of certain steps of the workflow may decrease hands-on time and the cost of the cell manufacturing process. Learn more.
The field of oncology biomarker testing is growing rapidly. With so many new cancer treatments available requiring specific biomarkers for prescription, oncologists have plenty of new information to follow and many decisions to make when treating individual tumors. Register now.
UNITY Biotechnology partnered with Rho to execute a complex and fast-moving Osteoarthritis program with three concurrent clinical trials and database locks scheduled during the height of the COVID-19 pandemic. In this webinar, hear from both the Sponsor and CRO about the creative solutions they implemented and how they worked together to pivot quickly and meet critical study timelines in the midst of the pandemic. Register Now.
Learn actionable and real-world recommendations from Honeywell’s experienced ICS/OT cybersecurity team, as they reveal how they’ve coached both sites and enterprises to establish a resilient ICS/OT cybersecurity program. Register Now!
Learn how Eli Lily put the power of text mining in the hands of primary (non-data-scientist) users through Linguamatics Web Portals. With the on-going information explosion, natural language processing (NLP)-based text mining has become important to gain meaning effectively from unstructured text. Register now.
Life science technology leaders will discuss how Apprentice.io’s pharma-compliant remote collaboration platform helped them steady supply chains, better manage operations, and increase speed to market during the pandemic. Hear about how the adoption of this platform helped their teams successfully navigate manufacturing challenges and ultimately deliver safer, more reliable drug products, treatments and therapies – from COVID to cancer. Register now.
Learn how Prognos Health and Datavant are transforming & improving the way life sciences can access an extensive network of integrated real world data sources to define an ideal patient cohort as well as key demographic, therapeutic & customer insights. Register now.
This Fierce webinar will feature executives from leading biopharma companies and technology-development firms, who will describe the latest tools and techniques for improving biomarker discovery. They will discuss how they chose and deployed these technologies, provide examples of how they led to the discovery of novel biomarkers, and offer tips for selecting tools to aid in biomarker discovery and incorporating them into established R&D processes. Register Today!
Sensors are transforming clinical trials by providing a 24/7 stream of objective insights into the health of patients. Sponsors, sites and most importantly patients all benefit from sensors, and use of the devices was on the rise even before COVID-19 turbocharged adoption. Yet, the nascent, fast-moving sensor sector poses challenges. Sponsors that navigate those challenges will be richly rewarded with clinical trials that generate new insights at record speeds. Download now.
Biotechnology companies of all sizes face many challenges in the development of new cell and gene therapies. In this webinar, Mike O’Mara and Dr. Ian Gaudet will introduce the development and manufacturing approach used by Miltenyi Biotec and describe how a CDMO partner focused in process and analytical development can enable clinical readiness. Register Now.
In 2020, consumers purchased over-the-counter (OTC) medicine heavily in March, but then shifted their consumption to vitamins and dietary supplements (VMS) for the remainder of the year. In this webinar, Catalent partnered with NielsenIQ to bring forward new insights that provide starting points for re-establishing growth via innovation in the OTC market. Save Your Spot - Register Now.
At each step in the product life cycle, pharma, biotech and medtech companies need to engage with third parties to develop, manufacture and sell their drugs, diagnostics and devices. With lives at stake and multiple players pursuing opportunities, companies that close deals quickly have a competitive edge. Yet, each contract exposes a company to an array of major third-party risks, creating a need for systems that support both speed and quality. Download this playbook to learn more.
Evolving R&D priorities and resource constraints across the globe mean clinical trials are more complex than ever. At the same time, COVID-19 has highlighted the urgent need for a more resilient and robust supply chain. Biopharma companies are heeding the call to innovate, be agile, reduce waste and, most of all, achieve patient-centricity. Flexible solutions like demand-led supply and direct-to-patient distribution are helping sponsors address the growing list of challenges presented by today’s increasingly complex studies. Download to learn more.
Attend this webinar to learn about the role neutralising antibody testing plays in antibody detection, response to mass vaccination, longevity of immunity to SARS-CoV-2, and examine performance characteristics data. Register now.
COVID-19 has resulted in delayed care across specialties. Join us as we discuss returning to pre-pandemic clinical activity and strategies that biopharma organizations are using to engage HCPs. Register now.
As the field of protein therapeutics pushes into higher and higher concentration space, unique challenges that require creative solutions are becoming more evident. Drawing from a combined 40 years of biologics formulation experience, we have distilled key takeaways from high concentration development into this whitepaper. Download now.
Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM, a rare, life-threatening neuromuscular disease, affecting about 1 in 40-50,000 newborn males. The session will review how IPM.ia and Audentes collaborated to uncover the XLMTM patient population. Register now.
March Is Multiple Myeloma Month. In recognition of this important month, join us for a Precision Key Opinion Leader (KOL) Insights series webinar. You’ll hear from two leading investigators on the lessons learned, current trends, and insights relevant to the Multiple Myeloma (MM) US and EU research community. Dr. Paul Richardson and Dr. Maria-Victoria Mateos have collectively published >700 papers and both have been recognized for excellence in MM research. This is a rare opportunity to get a look into current MM treatment. Register Now.
Cell, gene-modified cell and gene therapies hold the promise to offer new hope and novel therapeutic avenues for individuals facing serious illnesses and medical conditions. But bringing these therapies successfully through the clinical trial process introduces a level of supply chain risk, complexity and specialized requirements which are not yet fully understood. This webinar focuses on taking a closer look at unique clinical supply challenges and unique needs associated with cell and gene therapies. Register Now.
Patient-focused drug design can be a key factor in real-world therapeutic outcomes and business success. But if successful treatments should be created with patients in mind, when is the optimal time to solicit this feedback? And, what are the best methods for interacting with patients during drug development? This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Download Now.
In this webinar, industry experts discuss the recent advances, challenges and considerations in pediatric drug development. Real-life examples presented by the experts illustrate the impact of age-appropriate dose forms for pediatrics and highlight insights into the caregiver perspectives. Watch the webinar to learn about a case study on real-world medications and acceptability assessment. Download Now.
The incorporation of patient-focused drug design principles early in the development cycle is critical to developing safe and effective treatments that address the specific needs of target patient populations in-terms of appropriateness, preference and usability. Download this webinar to discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes.
Scaling up research procedures into clinical-scale manufacturing of new cellular therapeutics presents a challenge for many academic facilities. Join Drs. Adrian Gee and David McKenna in this live webinar for a discussion about the issues to be addressed when translating your cell and gene therapy research to the clinic; from picking your team to finding an effective culture system and beyond. Register Now.